Home › NDC Lookup › RxCUI directory › RxCUI 2628240

Sotorasib 320 MG Oral Tablet — RxCUI 2628240

RxNorm drug concept · Semantic clinical drug
RxCUI 2628240 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2628240
Official nameSotorasib 320 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)265 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sotorasib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • KRAS G12C is a specific genetic mutation found in some cancer cells that causes them to grow uncontrollably. It's like a stuck 'on' switch in the cancer cell. Lumakras was designed...
  • What exactly is Lumakras treating — what does the KRAS G12C mutation mean?
  • This is a really important one to talk about with your care team. Common heartburn and acid reflux medications — including PPIs like omeprazole or Prilosec, and H2 blockers like fa...
  • Can I take my heartburn medication while I'm on Lumakras?
📖 Read our full Sotorasib guide →

🕸️ Concept Web — How Sotorasib 320 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sotorasib 320 MG Oral Tablet RxCUI 2628240

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sotorasib 2550714
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lumakras 2550720
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sotorasib Oral Tablet 2550718
    • Sotorasib Oral Product 2550716
    • Sotorasib Pill 2550717
    • Sotorasib Oral Tablet [Lumakras] 2550722
    • Lumakras Oral Product 2550723
    • Lumakras Pill 2550724
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sotorasib 320 MG SCDC · 2628239
  • Sotorasib Oral Tablet SCDF · 2550718
  • Sotorasib Oral Product SCDG · 2550716
  • Sotorasib Pill SCDG · 2550717

Brand-Name Concepts

  • Sotorasib 320 MG Oral Tablet [Lumakras] SBD · 2628242
  • Sotorasib 320 MG [Lumakras] SBDC · 2628241
  • Sotorasib Oral Tablet [Lumakras] SBDF · 2550722
  • Lumakras Oral Product SBDG · 2550723
  • Lumakras Pill SBDG · 2550724
  • Lumakras BN · 2550720

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 2628240 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55513-0488-02 2 BOTTLE, PLASTIC in 1 CARTON (55513-488-02) / 120 TABLET,... LUMAKRAS Amgen Inc 2021-05-28
55513-0488-24 1 BOTTLE, PLASTIC in 1 CARTON (55513-488-24) / 240 TABLET,... LUMAKRAS Amgen Inc 2021-05-28
55513-0488-96 1 BOTTLE, PLASTIC in 1 CARTON (55513-488-96) / 120 TABLET,... LUMAKRAS Amgen Inc 2021-05-28
55513-0504-50 1 BOTTLE, PLASTIC in 1 CARTON (55513-504-50) / 90 TABLET, C... LUMAKRAS Amgen Inc 2023-02-02
55513-0512-60 1 BOTTLE, PLASTIC in 1 CARTON (55513-512-60) / 120 TABLET,... LUMAKRAS Amgen Inc 2024-06-27
Observed labelers: Amgen Inc (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.